If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Vertex is also developing a version called VX-264 in which the cells are encapsulated in a protective device designed to protect them from rejection by the immune system. A phase 1/2 trial of VX ...

Other companies working in this area include Canadian group Sernova, which has a phase 1/2 trial on the go for islet cells in its proprietary Cell Pouch device. With Vertex’ exon-skipping cystic ...

Brenton's work has previously appeared in Billboard, Pigeons & Planes and Complex. Vertex Pharmaceuticals A new painkiller has been approved for the first time in 25 years — and there's no risk ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

Bruker Corporation today announced the launch of the VERTEX NEO Platform today with its first product, the VERTEX NEO R. This release marks a continuation of providing high-end Fourier-Transform ...

Vertex Wireless, a leading wireless device distributor is proud to announce a new strategic collaboration with Samsung US Business channel and Pepperl+Fuchs. Our collaboration with Samsung and ...